z-logo
open-access-imgOpen Access
Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma
Author(s) -
Chelsea K. Osterman,
Allison M. Deal,
Matthew I. Milowsky,
Marc A. Bjurlin,
Tracy L. Rose
Publication year - 2020
Publication title -
kidney cancer
Language(s) - English
Resource type - Journals
eISSN - 2468-4570
pISSN - 2468-4562
DOI - 10.3233/kca-200089
Subject(s) - medicine , renal cell carcinoma , nivolumab , systemic therapy , immunotherapy , cancer , targeted therapy , oncology , breast cancer
The treatment landscape for metastatic clear cell renal cell carcinoma (mRCC) is rapidly changing. It is unknown how adoption of new types of therapies may differ by patient age.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here